Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Renal Denervation Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)The global renal denervation market is projected to grow from USD 1.44 billion in 2026 to USD 8.64 billion by 2036, at a CAGR of 19.6%. Growth is driven by rising resistant and uncontrolled hypertension, positive clinical trial results, regulatory approvals, reimbursement expansion, and advances in radiofrequency, ultrasound, and micro-infusion technologies. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes key products, technologies, indications, end users, regions, competitive strategies, and companies shaping this minimally invasive hypertension treatment market.
- Hagens Berman Sobol Shapiro LLPHims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit Before November 2, 2026 DeadlineHims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.Hagens Berman, which is actively investigating the alleged claims, encourages HIMS investors who suffered substantial losses to submit your losses now. Class Period: Aug. 4, 2025 -...
- AM Best Affirms Credit Ratings of Ping An Health Insurance Company of China, Ltd.Companies: Ping An InsuranceHONG KONG, September 04, 2026--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of "a" (Excellent) of Ping An Health Insurance Company of China, Ltd. (Ping An Health) (China). The outlook of these Credit Ratings (ratings) is stable.
- PhyxUp HealthPhyxUp Health Launches AI-Powered Billing Solution Built for RTM and Outpatient PracticesSAN FRANCISCO, September 04, 2026--A healthcare AI company PhyxUp Health launches PhyxUp Billing, an AI-powered solution automating RTM revenue cycle workflows for outpatient practices.
- Vagaro Unveils New Med Spa Software Capabilities That Turn Treatment Data Into RevenueSAN FRANCISCO, September 04, 2026--Vagaro, the leading software and app for medical spas and beauty, wellness, and fitness businesses, announced the launch of enhanced SOAP Notes and Custom Fields, two strategic HIPAA-compliant features designed to help med spas streamline clinical workflows, improve documentation accuracy, and better manage day-to-day operations.
- University of Medicine and Health Sciences, St. KittsUMHS Celebrates Residency Match Success with 94% Overall Match Rate and Inspiring Student JourneysMission-Driven Medical School Highlights 2026 Match Results, Including Nontraditional Student Dr. Tomika Moody's Journey to Residency at Age 52 — The University of Medicine and Health Sciences (UMHS), a small, mission-driven medical school with a...
- Trulieve Cannabis Corp.Trulieve to Open Medical Cannabis Dispensary in Dunwoody, GeorgiaNew DeKalb County location will host grand opening celebration Thursday, September 10 — Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the...
- AzentaAzenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical SystemsAzenta, Inc. (Nasdaq: AZTA) today announced that it has received repayment in full, prior to maturity, of the $35 million secured vendor loan extended in connection with the previously announced sale of B Medical Systems S.à r.l. to Thelema...
- Tyra BiosciencesTyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that...
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on September 1, 2026, the Compensation Committee of Taysha's Board of Directors granted five new employees restricted stock units (RSUs) representing 314,000 shares of the Company’s common stock and an option to purchase 92,400 shares of the Company's common stock in connection with their employment. The RSUs and stock option were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
- UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 19 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of JELMYTO® (mitomycin) for pyelocalyceal solution and ZUSDURI™ (mitomycin) for intravesical solution, UroGen’s only approved products, and the continued development of UroGen’s pipeline.
- Edison GroupEdison Issues Report on Percheron Therapeutics (PER)Edison issues report on Percheron Therapeutics (ASX: PER)Percheron's clinical strategy has taken an important turn with the announcement of an investigator-sponsored exploratory study of HMBD-002 in acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), led by Vanderbilt Health. Percheron's contribution will be limited to providing the study drug, a financial grant and advisory support. Following the announcement, the...